Literature DB >> 10657496

Distribution of calcitonin-gene-related peptide, neuropeptide-Y, vasoactive intestinal polypeptide, cholecystokinin-8, substance P and islet peptides in the pancreas of normal and diabetic rats.

E Adeghate1.   

Abstract

Neuropeptides and peptides are particularly important in the co-ordination of pancreatic exocrine and endocrine secretions. In diabetes mellitus, pancreatic endocrine secretion is particularly impaired. This study investigates whether there is a change in the pattern of distribution of neuropeptides including calcitonin-gene-related peptide (CGRP), neuropeptide-Y (NPY), vasoactive intestinal polypeptide (VIP), cholecystokinin-octapeptide (CCK-8), substance P (SP), and islet peptides including insulin (INS), glucagon (GLU), somatostatin (SOM) and pancreatic polypeptide (PP) in the pancreas of streptozotocin (STZ)-diabetic rats. After the onset of diabetes, the pattern of distribution of INS, GLU, SOM and PP cells was deranged. CGRP was demonstrated in ganglion cells of both normal and diabetic pancreas. CGRP was also localized in nerve fibres innervating the blood vessels of both normal and diabetic pancreas. The pancreata of both normal and diabetic rats contained numerous NPY-immunopositive varicose nerve fibres in the wall of blood vessels. In normal pancreatic tissue, VIP-immunopositive nerve fibres were observed in all areas of the pancreas. After the onset of diabetes, VIP-positive nerve fibres were still discernible in the interacinar regions of the pancreas. CCK-8 was identified in nerve fibres innervating both the normal and diabetic rat pancreata. These CCK-8-immunopositive nerves were varicose in nature and distributed in the wall of blood vessels. SP was demonstrated in neurons located in the interlobular areas of normal tissue and in fine varicose nerve fibres of the interacinar region of STZ-induced diabetic pancreas. In conclusion, CGRP, NPY, VIP, CCK-8 and SP are well distributed in both normal and diabetic pancreas. Copyright 1999 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10657496     DOI: 10.1054/npep.1999.0022

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  7 in total

1.  The vasoactive intestinal polypeptide (VIP) levels at the patients with ankylosing spondylitis and its association with inflammation markers.

Authors:  Selim Nalbant; Eylem Cagiltay; Burak Sahan; Hakan M Terekeci; Cagatay Oktenli
Journal:  Rheumatol Int       Date:  2010-03-26       Impact factor: 2.631

Review 2.  Unravelling innervation of pancreatic islets.

Authors:  Rollie F Hampton; Maria Jimenez-Gonzalez; Sarah A Stanley
Journal:  Diabetologia       Date:  2022-03-29       Impact factor: 10.460

3.  Diabetes Mellitus Alters the Immuno-Expression of Neuronal Nitric Oxide Synthase in the Rat Pancreas.

Authors:  Bright Starling Emerald; Sahar Mohsin; Crystal D'Souza; Annie John; Hussain El-Hasasna; Shreesh Ojha; Haider Raza; Basel Al-Ramadi; Ernest Adeghate
Journal:  Int J Mol Sci       Date:  2022-04-29       Impact factor: 6.208

4.  Glucagon secretion and signaling in the development of diabetes.

Authors:  Herbert Y Gaisano; Patrick E Macdonald; Mladen Vranic
Journal:  Front Physiol       Date:  2012-09-04       Impact factor: 4.566

5.  Glucagon Secreting Cells Responds to Insulin Secretion In vitro Using Immunocytochemistry.

Authors:  Mk Aswar; Um Aswar; Nk Subhedar
Journal:  J Young Pharm       Date:  2010-04

6.  Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats.

Authors:  Jessica T Y Yue; Elena Burdett; David H Coy; Adria Giacca; Suad Efendic; Mladen Vranic
Journal:  Diabetes       Date:  2011-11-21       Impact factor: 9.461

7.  Calcitonin gene-related peptide: neuroendocrine communication between the pancreas, gut, and brain in regulation of blood glucose.

Authors:  Sayali A Pendharkar; Monika Walia; Marie Drury; Maxim S Petrov
Journal:  Ann Transl Med       Date:  2017-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.